{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:26:43Z","timestamp":1782451603868,"version":"3.54.5"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background\/purpose<\/jats:title>\n                    <jats:p>COVID-19 mRNA vaccines have been reported to reduce severe COVID-19 outcomes in high-risk populations. In Japan, booster vaccinations up to the seventh dose are publicly funded; however, evidence regarding the safety and potential benefits of repeated booster doses in younger adults remains limited. This exploratory observational study aimed to describe age-specific patterns of all-cause mortality according to the number of COVID-19 vaccine doses using municipal administrative registry data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Municipal registry data obtained through information disclosure requests from Hamamatsu City (2021\u20132024) and Matsudo City (2021\u20132025) were analyzed. The dataset included age group or year of birth (5-year increments), sex, date of residence, COVID-19 vaccination records (date and lot number), and date of death. Individuals aged 20\u201389 years were categorized into three age groups (20\u201349, 50\u201364, and 65\u201389 years). All-cause mortality rates were calculated per 100,000 person-years according to the number of vaccine doses. Exploratory comparisons between dose groups were conducted using Poisson tests. Because the registry dataset lacked information on comorbidities, healthcare utilization, socioeconomic status, and cause of death, multivariable adjustment and causal inference were not feasible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age-specific differences in all-cause mortality rates were observed across vaccine dose groups. Among individuals aged 65\u201389 years, higher numbers of vaccine doses were associated with lower all-cause mortality rates. In contrast, among those aged 20\u201349 years, all-cause mortality rates were higher among individuals who had received \u22655 doses than among those who had received fewer doses. Among individuals aged 50\u201364 years, the all-cause mortality rate was higher among those who had received six doses than among those who had received 1, 3, or 4 doses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This exploratory analysis identified age-specific differences in all-cause mortality across COVID-19 vaccine dose groups. However, the dataset available so far lacked important clinical covariates and information on causes of death, limiting causal interpretation. These findings highlight the need for constructing in Japan nationally linked datasets that allow adjustment for comorbidities, healthcare utilization, and other potential confounders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1795437","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:23:26Z","timestamp":1776662606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Age-specific patterns of all-cause mortality across COVID-19 booster dose groups in two Japanese municipalities: an exploratory analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yasushi","family":"Iwamoto","sequence":"first","affiliation":[{"name":"Graduate School of Economics, The University of Tokyo","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kusunoki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Osaka Dental University","place":["Hirakata, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Kamijima","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University","place":["Kawagoe, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences","place":["Niigata, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kakeya","sequence":"additional","affiliation":[{"name":"Institute of Systems and Information Engineering, University of Tsukuba","place":["Tsukuba, Japan"]},{"name":"Transdisciplinary Review Association","place":["Moriya, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1056\/NEJMoa2201688","article-title":"Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting","volume":"386","author":"Magen","year":"2022","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/vaccines12121413","article-title":"Current status and significance of additional vaccination with COVID-19 vaccine in Japan: considerations from antibody levels from hybrid immunity and public perceptions","volume":"12","author":"Kusunoki","year":"2024","journal-title":"Vaccines."},{"key":"B4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.31662\/jmaj.2024-0298","article-title":"Significant increase in excess deaths after repeated COVID-19 vaccination in Japan","volume":"8","author":"Kakeya","year":"2025","journal-title":"JMA J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e002357","DOI":"10.1136\/bmjph-2024-002357","article-title":"Excess mortality during and after the COVID-19 emergency in Japan: a two-stage interrupted time-series design","volume":"3","author":"Devanathan","year":"2025","journal-title":"BMJ Public Health."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/healthcare13111305","article-title":"Unraveling rising mortality: statistical insights from Japan and international comparisons","volume":"13","author":"Kusunoki","year":"2025","journal-title":"Healthcare."},{"key":"B7","unstructured":"Nagai\n              T\n            \n          \n          How did the trend in mortality risk in Japan change from 2022 to 2023 towards the end of the COVID-19 pandemic?\n          \n          2023"},{"key":"B8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14760584.2024.2310807","article-title":"Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines during the SARS-CoV-2 Omicron BA","volume":"23","author":"Maeda","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3138\/jammi-2022-0002","article-title":"Testing behaviour may bias observational studies of vaccine effectiveness","volume":"7","author":"Glasziou","year":"2022","journal-title":"J Assoc Med Microbiol Infect Dis Can."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/pds.4298","article-title":"Controlling confounding by frailty when estimating influenza vaccine effectiveness using predictors of dependency in activities of daily living","volume":"26","author":"Zhang","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/EDE.0000000000001116","article-title":"The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology","volume":"31","author":"Chua","year":"2020","journal-title":"Epidemiology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1038\/s41467-024-45549-9","article-title":"Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States","volume":"15","author":"Park","year":"2024","journal-title":"Nat Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2546822","DOI":"10.1001\/jamanetworkopen.2025.46822","article-title":"COVID-19 mRNA vaccination and 4-year all-cause mortality among adults aged 18\u201359 years in France","volume":"8","author":"Semenzato","year":"2025","journal-title":"JAMA Netw Open."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e001859","DOI":"10.1136\/bmjph-2024-001859","article-title":"COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021\u20132023: a population-based cohort study","volume":"4","author":"Dahl","year":"2026","journal-title":"BMJ Public Health."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41467-024-45953-1","article-title":"Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection","volume":"15","author":"Lam","year":"2024","journal-title":"Nat Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1474045","DOI":"10.3389\/fmed.2024.1474045","article-title":"Biases in COVID-19 vaccine effectiveness studies using cohort design","volume":"11","author":"Agampodi","year":"2024","journal-title":"Front Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12879-015-1154-y","article-title":"Frequency and impact of confounding by indication and healthy vaccinee bias in influenza vaccine effectiveness studies: a systematic review","volume":"15","author":"Remschmidt","year":"2015","journal-title":"BMC Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"107143","DOI":"10.1016\/j.ijid.2024.107143","article-title":"Failure to address crucial biases other than the healthy vaccinee effect","volume":"146","author":"Jedli\u010dka","year":"2024","journal-title":"Int J Infect Dis."},{"key":"B19","unstructured":"The Statistics Bureau and the Director-General for Policy Planning (Statistical Standards) of Japan."},{"key":"B20","unstructured":"Hamamatsu City statistics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e103690","DOI":"10.7554\/eLife.103690","article-title":"Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar","volume":"14","author":"Chemaitelly","year":"2025","journal-title":"eLife."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMoa2510226","article-title":"Association of 2024\u20132025 COVID-19 vaccine with COVID-19 outcomes in U","volume":"393","author":"Cai","year":"2025","journal-title":"N Engl J Med."},{"key":"B23","unstructured":"Japanese Association for Infectious Diseases\n          \n          2025"},{"key":"B24","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/CLEP.S553894","article-title":"Taiwan's national health insurance research database (NHIRD): in the era of artificial intelligence, causal inference, and data security","volume":"17","author":"Hsieh","year":"2025","journal-title":"Clin Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish national patient registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1016\/j.vaccine.2023.03.059","article-title":"Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: the VENUS study","volume":"41","author":"Fukuda","year":"2023","journal-title":"Vaccine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.35772\/ghmo.2024.01007","article-title":"Validity of vaccination information in the COVID-19 surveillance system in Japan","volume":"4","author":"Horie","year":"2024","journal-title":"GHM Open."},{"key":"B29","unstructured":"Cabinet\n              Office for Infectious Disease Crisis Management\n            \n          \n          The national action plan for novel influenza, etc\n          \n          2024"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1795437\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:23:28Z","timestamp":1776662608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1795437\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2026.1795437"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1795437","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1795437"}}